FDA
approval
· 2022-01-26
FDA Approved: BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE — Original Application (Hikma Pharmaceuticals USA Inc.)
Summary
FDA approved Hikma Pharmaceuticals USA's generic fixed-dose combination of butalbital, acetaminophen, caffeine and codeine phosphate (Original Application).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE (BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE)